• Search History (Register)
  • MeSH Browser
  • [Clear]
    • English

Welcome to the international HTA database


Showing [16381 Records] Selected Records [0 Hits] [Clear]
Year Source Title
2023     Agency for Care Effectiveness (ACE) Zio XT for ambulatory ECG monitoring for patients suspected to have cardiac arrhythmia
2023     Agency for Care Effectiveness (ACE) Cytosponge for the detection of patients with Barrett oesophagus
2023     Agency for Care Effectiveness (ACE) Sirolimus-coated percutaneous transluminal coronary angioplasty balloon catheters (SCBs) for patients with coronary artery disease (CAD)
2023     Agency for Care Effectiveness (ACE) Thoracic and abdominal endovascular repair (T/EVAR) for the structural support of aortic aneurysm
2023     Agency for Care Effectiveness (ACE) Aortic hybrid stent graft for treating complex aortic disease
2023     Agency for Care Effectiveness (ACE) SpaceOAR systems for rectum protection during prostate cancer treatment
2023     Agency for Care Effectiveness (ACE) Minimally invasive glaucoma surgery (MIGS) implants for treating patients with mild to moderate primary open-angle glaucoma (POAG)
2023     Agency for Care Effectiveness (ACE) Presbyopia-correcting intraocular lenses for treating patients with cataract
2023     Agency for Care Effectiveness (ACE) Dexamethasone intravitreal implant for treating diabetic macular oedema, retinal vein occlusion and non-infectious uveitis
2023     Agency for Care Effectiveness (ACE) Trastuzumab deruxtecan for previously treated HER2-positive metastatic breast cancer
2023     Agency for Care Effectiveness (ACE) Trastuzumab deruxtecan for treating HER2-positive advanced gastric cancer after two or more therapies
2023     Agency for Care Effectiveness (ACE) Botulinum toxin A for the management of focal spasticity of the lower limbs associated with stroke in adults
2023     Agency for Care Effectiveness (ACE) Ixekizumab and secukinumab for treating active non-radiographic axial spondyloarthritis
2023     Agency for Care Effectiveness (ACE) Romosozumab and teriparatide for treating osteoporosis
2023     Health Information and Quality Authority (HIQA) 18F-PSMA PET/CT in the staging of primary prostate cancer and the restaging of recurrent prostate cancer: evidence synthesis to support a generic justification decision
2023     Penn Medicine Center for Evidence-based Practice (CEP) Antibiotic products for treatment of trauma-related osteomyelitis
2023     Swiss Federal Office of Public Health (FOPH) Calcitonin gene-related peptide antagonists for the prevention of migraine
2023     Swiss Federal Office of Public Health (FOPH) Revascularisation versus optimal medical therapy (OMT) for the treatment of chronic coronary syndrome (CCS)
2023     Swiss Federal Office of Public Health (FOPH) Folate tests for suspected folate deficiency
2023     Swiss Federal Office of Public Health (FOPH) Oral anticoagulants for the prevention of stroke and systemic embolism in people with non-valvular atrial fibrillation
2023     NIHR Health Technology Assessment programme A multifaceted intervention to reduce antibiotic prescribing among CHIldren with acute COugh and respiratory tract infection: the CHICO cluster RCT
2023     NIHR Health Technology Assessment programme Tonsillectomy compared with conservative management in patients over 16 years with recurrent sore throat: the NATTINA RCT and economic evaluation
2023     Health Technology Wales (HTW) Solution-focused assessment tools for improving the treatment of people with psychosis and schizophrenia within secondary mental health services
2023     Health Technology Wales (HTW) Percutaneous implantation of pulmonary artery pressure sensors for monitoring treatment of chronic heart failure
2023     Austrian Institute for Health Technology Assessment (AIHTA) SMA therapies: mid- to long-term follow-up of spinal muscular atrophy (SMA) patients treated for ≥24 months with nusinersen or onasemnogene abeparvovec and ≥12 months for patients treated with risdiplam or combination therapies
2023     Austrian Institute for Health Technology Assessment (AIHTA) Image-guided spinal injections in the treatment of chronic spinal pain: an overview of evidence-based guideline recommendations and specific focus on guidance techniques
2023     NIHR Health Technology Assessment programme Techniques to increase lumbar puncture success in newborn babies: the NeoCLEAR RCT
2023     NIHR Health Technology Assessment programme Treatment of Hidradenitis Suppurativa Evaluation Study: the THESEUS prospective cohort study
2023     NIHR Health Technology Assessment programme Ablative and non-surgical therapies for early and very early hepatocellular carcinoma: a systematic review and network meta-analysis
2023     NIHR Health Services and Delivery Research programme Evaluating mental health decision units in acute care pathways (DECISION): a quasi-experimental, qualitative and health economic evaluation
2023     NIHR Health Technology Assessment programme The potential impact of policies and structural interventions in reducing cardiovascular disease and mortality: a systematic review of simulation-based studies
2023     NIHR Health Services and Delivery Research programme The effectiveness and acceptability of multimedia information when recruiting children and young people to trials: the TRECA meta-analysis of SWATs
2023     NIHR Health Services and Delivery Research programme Impact of interventions to improve recovery of older adults following planned hospital admission on quality-of-life following discharge: linked-evidence synthesis
2023     WorkSafeBC Creatine supplementation for treating concussions
2023     WorkSafeBC Glutamine for treating concussions
2023     WorkSafeBC Koebner phenomenon in connective tissue
2023     WorkSafeBC The effect of pepper spray on human health
2023     WorkSafeBC Myalgic encephalomyelitis/chronic fatigue syndrome associated with mRNA COVID-19 vaccination
2023     WorkSafeBC Platelet rich plasma as treatment for medial epicondylitis
2023     Scottish Health Technologies Group (SHTG) Digital prevention programme for people at risk of type 2 diabetes
2023     Scottish Health Technologies Group (SHTG) Technology-enabled theatre scheduling systems
2023     Scottish Health Technologies Group (SHTG) Capsule sponge technologies for the detection of Barrett’s oesophagus and early stage oesophageal cancer
2023     Scottish Health Technologies Group (SHTG) The cost-effectiveness of the Scottish Hip Fracture Audit
2023     Scottish Health Technologies Group (SHTG) Priorities for the north imaging alliance
2023     Malaysian Health Technology Assessment (MaHTAS) Negative pressure wound therapy
2023     Malaysian Health Technology Assessment (MaHTAS) Human skin allograft for burns
2023     Malaysian Health Technology Assessment (MaHTAS) Nasojejunal tube in upper gastrointestinal conditions
2023     Malaysian Health Technology Assessment (MaHTAS) Bio-electrical impedance analysis for the assessment of sarcopenia in elderly
2023     NIHR Health Technology Assessment programme Implementing early rehabilitation and mobilisation for children in UK paediatric intensive care units: the PERMIT feasibility study
2023     Health Information and Quality Authority (HIQA) Health technology assessment of the addition of spinal muscular atrophy (SMA) to the National Newborn Bloodspot Screening Programme
2023     Health Information and Quality Authority (HIQA) An overview of national approaches to stockpiling of medical countermeasures for public health emergencies
2023     Health Information and Quality Authority (HIQA) Ultra-hypofractionated adjuvant radiotherapy for breast cancer: evidence synthesis to support a generic justification decision
2023     WorkSafeBC Low intensity pulsed ultrasound (LIPUS) for preventing fractures
2023     WorkSafeBC Efficacy of eye movement desensitization and reprocessing (EMDR) as treatment for major depression
2023     WorkSafeBC Firefighting and polycythemia vera
2023     WorkSafeBC HEPA filters and nanomaterials
2023     WorkSafeBC Hemorrhoids and heavy lifting
2023     WorkSafeBC Association between wearing orthosis and developing metatarsal stress fractures
2023     WorkSafeBC Causal association between firefighting and hypersensitivity pneumonitis
2023     NIHR Health Services and Delivery Research programme Remote monitoring for long-term physical health conditions: an evidence and gap map
2023     NIHR Health Services and Delivery Research programme What factors are associated with informal carers’ psychological morbidity during end-of-life home care? A systematic review and thematic synthesis of observational quantitative studies
2023     NIHR Health Technology Assessment programme One versus three weeks hypofractionated whole breast radiotherapy for early breast cancer treatment: the FAST-Forward phase III RCT
2023     Penn Medicine Center for Evidence-based Practice (CEP) Antibiotic-laden bone cement
2023     NIHR Health Technology Assessment programme Pragmatic randomised controlled trial of guided self-help versus individual cognitive behavioural therapy with a trauma focus for post-traumatic stress disorder (RAPID)
2023     NIHR Health Technology Assessment programme Appropriate design and reporting of superiority, equivalence and non-inferiority clinical trials incorporating a benefit–risk assessment: the BRAINS study including expert workshop
2023     Penn Medicine Center for Evidence-based Practice (CEP) Medication review and reconciliation in the outpatient setting
2023     Canadian Agency for Drugs and Technologies in Health (CADTH) Routine dental polishing for oral health
2023     Canadian Agency for Drugs and Technologies in Health (CADTH) Intraocular lenses for cataract surgery
2023     Canadian Agency for Drugs and Technologies in Health (CADTH) Refractive laser surgery for vision conditions
2023     Canadian Agency for Drugs and Technologies in Health (CADTH) Buprenorphine naloxone film versus tablets for opioid use disorder
2023     Canadian Agency for Drugs and Technologies in Health (CADTH) Case carts in surgical settings
2023     Canadian Agency for Drugs and Technologies in Health (CADTH) Anti–vascular endothelial growth factor drugs for age-related macular degeneration
2023     Canadian Agency for Drugs and Technologies in Health (CADTH) Point of care ultrasound for guided central venous catheter insertion
2023     Canadian Agency for Drugs and Technologies in Health (CADTH) IV acetaminophen for acute pain in emergency departments
2023     Canadian Agency for Drugs and Technologies in Health (CADTH) Semaglutide 2 mg for type 2 diabetes
2023     Canadian Agency for Drugs and Technologies in Health (CADTH) Midline and extended dwell catheters for IV antibiotics
2023     Canadian Agency for Drugs and Technologies in Health (CADTH) Radiofrequency ablation for chronic knee, hip, and shoulder pain
2023     Canadian Agency for Drugs and Technologies in Health (CADTH) Direct-acting antivirals for pediatric chronic hepatitis C virus infection
2023     Canadian Agency for Drugs and Technologies in Health (CADTH) Somatropin for short stature
2023     Canadian Agency for Drugs and Technologies in Health (CADTH) Non-sterile glove use
2023     NIHR Health Services and Delivery Research programme The effectiveness of sexual assault referral centres with regard to mental health and substance use: a national mixed-methods study – the MiMoS Study
2023     Penn Medicine Center for Evidence-based Practice (CEP) Embolization vs. conservative management for spontaneous abdominal or pelvic hemorrhage
2023     NIHR Health Technology Assessment programme Alternative cascade-testing protocols for identifying and managing patients with familial hypercholesterolaemia: systematic reviews, qualitative study and cost-effectiveness analysis
2023     NIHR Health Services and Delivery Research programme Eye donation from palliative and hospice care contexts: the EDiPPPP mixed-methods study
2023     NIHR Health Technology Assessment programme A pragmatic, multicentre, double-blind, placebo-controlled randomised trial to assess the safety, clinical and cost-effectiveness of mirtazapine and carbamazepine in people with Alzheimer’s disease and agitated behaviours: the HTA-SYMBAD trial
2023     NIHR Health Technology Assessment programme Exercise therapy for tendinopathy: a mixed-methods evidence synthesis exploring feasibility, acceptability and effectiveness
2023     NIHR Health Technology Assessment programme Posterior cervical foraminotomy versus anterior cervical discectomy for cervical brachialgia: the FORVAD RCT
2023     NIHR Health and Social Care Delivery Program Adjunctive Medication Management and Contingency Management to enhance adherence to acamprosate for alcohol dependence: the ADAM trial RCT
2023     NIHR Health Technology Assessment programme Comparison of lotions, creams, gels and ointments for the treatment of childhood eczema: the BEE RCT
2023     NIHR Health Technology Assessment programme Alternative cascade-testing protocols for identifying and managing patients with familial hypercholesterolaemia: systematic reviews, qualitative study and cost-effectiveness analysis
2023     NIHR Health Technology Assessment programme Rates of medical or surgical treatment for women with heavy menstrual bleeding: the ECLIPSE trial 10-year observational follow-up study
2023     NIHR Health Technology Assessment programme Online remote behavioural intervention for tics in 9- to 17-year-olds: the ORBIT RCT with embedded process and economic evaluation
2023     Ontario Health Bariatric surgery for adults with class I obesity and difficult-to-manage type 2 diabetes
2023     Ontario Health Robotic-assisted hysterectomy for endometrial cancer in people with obesity: a health technology assessment
2023     NIHR Health Services and Delivery Research programme Rapid evaluation of the Special Measures for Quality and challenged provider regimes: a mixed-methods study
2023     NIHR Health Services and Delivery Research programme Reducing unplanned hospital admissions from care homes: a systematic review
2023     Health Information and Quality Authority (HIQA) Overview of multiplex antigen near-patient tests for acute respiratory infections
2023     NIHR Health Services and Delivery Research programme Involving carer advisors in evidence synthesis to improve carers’ mental health during end-of-life home care: co-production during COVID-19 remote working
2023     NIHR Health Technology Assessment programme Extracorporeal carbon dioxide removal compared to ventilation alone in patients with acute hypoxaemic respiratory failure: cost-utility analysis of the REST RCT
2023     NIHR Health Services and Delivery Research programme Understanding what affects psychological morbidity in informal carers when providing care at home for patients at the end of life: a systematic qualitative evidence synthesis